EEF1GP2: A Drug Target / Disease Biomarker (G100130260)

Target Name: EEF1GP2

NCBI ID: G100130260

EEF1GP2

Other Name(s): eukaryotic translation elongation factor 1 gamma pseudogene 2 | Eukaryotic translation elongation factor 1 gamma pseudogene 2

EEF1GP2: A Drug Target / Disease Biomarker

EEF1GP2, also known as EEF1A, is a protein that is expressed in various tissues throughout the body. Its function is not well understood, but research has shown that it plays a role in several cellular processes, including cell signaling, inflammation, and stress responses. As a result, EEF1GP2 has been identified as a potential drug target and biomarker for several diseases.

One of the key functions of EEF1GP2 is its role in cell signaling. This protein is a component of several signaling pathways that are involved in cell growth, differentiation, and survival. For example, EEF1GP2 has been shown to be involved in the TGF-β pathway, a well-established signaling pathway that plays a role in regulating cell growth and differentiation.

In addition to its role in cell signaling, EEF1GP2 is also involved in the regulation of inflammation. This protein has been shown to be involved in the production of pro-inflammatory cytokines, such as TNF-伪 and IL-1尾. These cytokines can contribute to the development of inflammatory diseases, such as cancer, autoimmune diseases, and chronic obstructive pulmonary disease (COPD).

Another function of EEF1GP2 is its role in stress responses. This protein has been shown to be involved in the regulation of cellular stress responses, including the production of reactive oxygen species (ROS) and the expression of genes involved in stress response. These processes can contribute to the development of stress-related diseases, such as neurodegenerative diseases and cancer.

In addition to its role in cell signaling, EEF1GP2 is also a potential biomarker for several diseases. For example, this protein has been shown to be involved in the development of cancer, both in humans and animals. In addition, EEF1GP2 has been shown to be involved in the development of autoimmune diseases, such as rheumatoid arthritis and type 1 diabetes.

Overall, EEF1GP2 is a protein that has significant implications for our understanding of several cellular processes and its potential as a drug target and biomarker. Further research is needed to fully understand its functions and the potential implications of targeting it in therapy.

Protein Name: Eukaryotic Translation Elongation Factor 1 Gamma Pseudogene 2

The "EEF1GP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EEF1GP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets